No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - EKF Diagnostics said on Friday that it had purchased 50,000 of its own shares as part of its share buyback programme.
The AIM-traded global diagnostics business bought the shares on 11 June at a price of 24.8p each, giving the transaction a total value of about 12,400.
The highest, lowest and volume-weighted average prices paid were all 24.8p per share.
EKF said the purchased shares would be cancelled.
Following cancellation, the company's issued share capital will comprise 430,333,112 ordinary shares, all carrying voting rights.
The company holds no shares in treasury.
At 1137 BST, shares in EKF Diagnostics Holdings were down 1.8% at 25.04p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.